Vaccine Design pp 111-118 | Cite as

Modulation of Cytokine Responses by Iscoms and Iscom-Matrix

  • Maria Villacres-Eriksson
  • Shahriar Behboudi
  • Karin Lövgren-Bengtsson
  • Bror Morein
Chapter
Part of the NATO ASI Series book series (NSSA, volume 293)

Abstract

The immunomodulating complex (iscom) is a formulation in which protein antigens are coincorporated with glycosylated triterpenoids possessing adjuvant activity in the same particle (Morein et al, 1984). In electron microscopy, the iscoms appear as organized cage-like structures of 30–40 nm in diameter (Özel et al, 1989). Chemically, iscoms consist of glycosylated triterpenoids from Quillaja saponaria Molina, cholesterol, phospholipids and amphipathic protein antigens (Lövgren and Morein, 1988a). Complexes prepared without protein are called iscom-matrix (matrix) and have the same electron microscopic morphology as iscoms (Özel et al, 1989). The basic concept of the iscom is to deliver the adjuvant and the protein antigen in the same particle, assuring optimal activation of antigen-presenting cells (APC).

Keywords

Influenza Virus Rabies Virus Protein Antigen Bovine Virus Diarrhoea Virus Trypanosoma Cruzi 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Araujo, F and Morein, B. 1991, Immunization with Trypanozoma cruzi epimastigote antigens incorporated into iscoms protects against lethal challenge in mice. Inf. Immun., 59: 2909.Google Scholar
  2. Behboudi, S., Morein, B. and Villacres-Eriksson, M. 1996, In vitro activation of antigen-presenting cells (APC) by defined composition of Ouillaja saponaria Molina triterpenoids. Clin. Exp. Immunol., 105: 26.PubMedCrossRefGoogle Scholar
  3. Behboudi, S., Morein, B. and Villacres-Eriksson, M. 1997, In vivo and in vitro induction of IL-6 by Ouillaja saponaria Molina triterpenoid formulations. Cytokine. in press.Google Scholar
  4. Ben Ahmeida, E.T.S., Jennings, R., Erturk, M., and Potter, C.W., 1992, The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as iscoms, with FCA, ALH or as infectious virus, Arch Virol. 125: 71.PubMedCrossRefGoogle Scholar
  5. Bergström-Mollaoglu, M., Lövgren, K., Åkerblom, L., Fossum, C.K. and Morein, B. 1992, Antigen-specific increases in the number of splenocytes expressing MHC class II molecules following restimulation with antigen in various physical forms. Scand.J. Immunol., 36: 565.PubMedCrossRefGoogle Scholar
  6. Carlomagno, M., Hansen, D., Åkerblom, L., Esteva, M.I., Villacres-Eriksson, M., Segura, E., and Morein, B. Stimulation of IL-2 by immunization without concominant stimulation of IFN-ε does not provide protection against Trvpanosoma cruzi infection. Submitted Manuscript.Google Scholar
  7. Carlson, U., Alenius, S., and Sudquist, B., 1991, Protective effect of an iscom bovine virus diarrhoea virus (BVDV) vaccine against an experimental BVDV infection in vaccinated and non-vaccinated pregnant ewes, Vaccine, 9: 577.CrossRefGoogle Scholar
  8. De Vries, P., Van Binnendijk, R.S., Van der Marel, P., Van Wezel, A.L., Voorma, H.O., Sundquist, B., UytdeHaag, F.G.C.M. and Osterhaus, A.D.M.E., 1988a, Measles virus fusion protein presented in an immune stimulating complex (iscom) induces haemolysis-inhibiting and fusion inhibiting antibodies, virus-specific T cells and protection in mice. J. Gen. Virol., 69: 549.PubMedCrossRefGoogle Scholar
  9. De Vries, P., UytdeHaag, F.G.C.M., and Osterhaus, A.D.M.E., 1988b, Canine distemper virus (CDV) immunestimulating complex (iscom), but not measles virus iscoms, protects dogs against CDV infection, J.Gen.Virol., 69: 2071.PubMedCrossRefGoogle Scholar
  10. Dotsika, E., Karagouni, E., Sundquist, B., Morein, B., Morgan, A. and Villacres-Eriksson, M., 1997, Influence of Ouillaja saponaria triterpenoid content on the immunomodulatory capacity of Epstein-Barr virus (EBV) iscoms. Scand.J.Immunol., 45: 261.PubMedCrossRefGoogle Scholar
  11. Erturk, M., Jennings, R., Hockley, D., and Potter, C.W., 1989, Antibody response and protection in mice immunized with herpes simplex virus type I antigen immuno-stimulating complex preparations. J.Gen.Virol., 70: 2149.PubMedCrossRefGoogle Scholar
  12. Erturk, M., Hill, T.J., Shimeld, C. and Jennings, R., 1992, Acute and latent infection of mice immunized with HSV-1 iscom vaccine. Arch. Virol., 125: 87.PubMedCrossRefGoogle Scholar
  13. Fekadu, M., Shaddock, J.H., Ekström, J., Osterhaus, A.D.M.E., Sanderlin, D.W., Sundquist, B. and Morein, B. 1992, An immune stimulating complex subunit rabies virus vaccine protects mice and dogs against street rabies challenge, Vaccine. 10: 192.PubMedCrossRefGoogle Scholar
  14. Fossum, C., Bergström, M., Lövgren, K., Watson, D.L. and Morein, B. 1990, Effect of iscom and/or their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses in vitro. Comparison of spleen cells from mice inoculated with iscoms and/or matrix. Cell. Immunol., 129: 414.PubMedCrossRefGoogle Scholar
  15. Gajewski, T.F., Renauld, J.C., Pel, A.V. and Boon, T. 1995, Costimulation with B7-1, IL-6 and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro. J. Immunol., 154: 5637.PubMedGoogle Scholar
  16. Hansen, D., Villacres-Eriksson, M., Akerblom, L., Hellman, U., Segura, E., Carlomagno, M. and Morein, B. 1997, An immunoaffmity purified Trypanosoma cruzi antigen supresses cellular proliferation through a TGF-γ-mediated mechanism. Scand. J. Immunol., in press.Google Scholar
  17. Jones, P.D., Tha Hla, R., Morein, B., Lövgren, K. and Ada, G.L., 1988, Cellular immune responses in the murine lung to local immunization with influenza A virus glycoproteins in micelles and immunostimulatory complexes (iscoms), Scand. J. Immunol., 27: 645.PubMedCrossRefGoogle Scholar
  18. Jones, G.E., Jones, K.A., Machell, J., Brebner, J., Anderson, I.E. and How, S. 1995, Efficacy trials with tissue-culture grown, inactivated vaccines against chamydial abortion in sheep. Vaccine. 13: 715.PubMedCrossRefGoogle Scholar
  19. Lövgren, K. and Morein, B., 1988a. The requirement of lipids for the formation of immuno-stimulating complexes (iscoms). Biotechnol. Appl. Biochem., 10: 161.PubMedGoogle Scholar
  20. Lövgren, K. 1988b, The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes. Scand. J. Immunol., 27: 241.PubMedCrossRefGoogle Scholar
  21. Lövgren, K., Kåberg, H. and Morein, B., 1990, An experimental subunit vaccine (iscom) induced portective immunity to influenza virus infection in mice after a single intranasal administration. Clin. Exp. Immunol., 82: 435.PubMedCrossRefGoogle Scholar
  22. Lövgren Bengtsson, K. and Sjölander, A. 1996, Adjuvant activities of iscoms and iscom matrix; two different formulations of Quillaja saponin and antigen. Vaccine. 14: 753.CrossRefGoogle Scholar
  23. Lunden, A., Lövgren, K., Uggia, A. and Araujo, F.G. 1993, Immune response and resistance to Toxoplasma gondii in mice immunized with antigens of parasite incorporated into imunostimulating complexes. Infect. Immun., 6: 2639.Google Scholar
  24. Morein, B., Sundquist, B., Höglund, S., Dalsgaard, K. and Osterhaus, A., 1984. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature. 308: 457.PubMedCrossRefGoogle Scholar
  25. Morein, B., Lövgren, K., Rönnberg, B., Sjölander, A. and Villacres-Eriksson, M. 1995, Immunostimulating complex: Clinical potential in vaccine development. Clin. Immunother., 6: 461.CrossRefGoogle Scholar
  26. Morgan, A.J., Finerty, S., Lövgren, K., Scullion, F.T. and Morein, B. 1988, Protection of Epstein-Barr (EB) virus-induced lymphoma in cottontop tamarins by vaccinations with the EB virus envelope glycoprotein gp340 incorporated into immunostimulating complexes, J. Gen. virol., 69: 2093.PubMedCrossRefGoogle Scholar
  27. Mowat, A.M., Donachie, A.M., Reid, G. and Jarret, O., 1991, Immune-stimulating complexes containing Quil A and protein antigen prime class IMHC restricted T lymphocytes in vivo and are immunogenic by the oral route, Immunology, 72: 317–322.PubMedGoogle Scholar
  28. Mowat, A. M., Maloy, K. J., Donachie, A. M., 1993, Immune-stimulating complexes as adjuvants for inducing local and systemic immunity after oral imunization with protein antigen. Immunology, 80: 527.PubMedGoogle Scholar
  29. Nordengrahn, A., Rusvai, M., Merza, M., Ekström, J., Morein, B. and Belak, S., 1996, Equine herpes virus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: prevention of the bifactorial disease with EHV-2 immunostimulating complexes. Vet. Microbiol., 51: 55.PubMedCrossRefGoogle Scholar
  30. Osterhaus, A.D.M.E., Weijer, K., UytdeHaage, F.G.C.M., Knell, P., Jarret, O., Sundquist, B., and Morein, B., 1985, Induction of protective immune response in cats by vaccination with feline leukaemia virus iscoms. J. Immunol., 135: 591.PubMedGoogle Scholar
  31. Osterhaus, A.D.M.E., Weijer, K., UytdeHaage, F.G.C.M., Knell, P., Jarret, O. and Morein, B., 1989, Serological response in cats vaccinated with FeLV iscom and an inactivated FeLV vaccine, Vaccine. 7: 137.PubMedCrossRefGoogle Scholar
  32. Osterhaus, A.D.M.E., De Vries, P., and Heeney, J. 1992a, AIDS vaccine developments, Nature. 355: 684.PubMedCrossRefGoogle Scholar
  33. Osterhaus, A.D.M.E., De Vries, P., Morein, B., Åkerblom, L. and Heeney, J. 1992b, Comparison of protection afforded by whole virus iscom versus MDP-adjuvanted formalin inactivated SIV vaccines from iv cell-free or cell associated homologous challenge, AIDS Res. Hum. Retroviruses, 8: 1507.PubMedGoogle Scholar
  34. Özel, M., Höglund, S., Gelderblom, H.R. and Morein, B., 1989. Quaternary structure of the immunostimulating complex (iscom). J. Ultrastructure Mol. Structure Res., 102: 240.CrossRefGoogle Scholar
  35. Renauld, J. C., Vink, A. and Snick, J. 1989, Accessory signals in murine cytolytic T cell responses. Dual requirement for IL-1 and IL-6. J. Immunol., 15: 143 (6) 1894.Google Scholar
  36. Rönnberg, B., Fekadu, M. and Morein, B., 1995. Adjuvant activity of non toxic Ouillaja saponaria Molina components for use in iscom-matrix. Vaccine, 13: 1375.PubMedCrossRefGoogle Scholar
  37. Sjölander, S., Hansen, J.E., Lövgren Bengtsson, K., Åkerblom, L. and Morein, B. 1996 Induction of homologous virus neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp 120-iscom preparations. A comparison with other adjuvant systems. Vaccine. 14: 344.PubMedCrossRefGoogle Scholar
  38. Snodgrass, D.R., Campbell, I., Mwenda, J.M., Chege, G., Seleman, M.A., Morein, B., and Hart, C.A. 1995, Stimulation of rotavirus IgA, IgG and neutralising antibodies in baboon milk by parenteral vaccination. Vaccine, 13: 408.PubMedCrossRefGoogle Scholar
  39. Sundquist, B., Lövgren, K., and Morein, B., 1988, Influenza virus iscoms: Antibody response in animals, Vaccine, 6: 49.PubMedCrossRefGoogle Scholar
  40. Sundquist, B., Czifra, Gy. and Stipkovits, L. 1996, Protective immunity induced in chicken by a single immunization with mvcoplasma gallisepticum immunostimulating complexes (ISCOMS). Vaccine, 9: 892.CrossRefGoogle Scholar
  41. Takahashi, H., Takeshita, T., Morein, B., Putney, S., Germain, R.N. and Berzofsky, J.A., 1990, Induction of CD8 cytotoxic T cells by immunization with purified HIV-1 envelope protein in iscoms, Nature, 344: 873.PubMedCrossRefGoogle Scholar
  42. Trudel, M., Nadon, F., Seguin, C., Boulay, G. and Lussier, G., 1987, Vaccination of rabbits with a bovine herpes type I subunit vaccine: Adjuvant effect of iscoms, Vaccine, 5: 239.PubMedCrossRefGoogle Scholar
  43. Trudel, M., Boulay, G., Seguin, C., Nadon, F. and Lussier, G., 1988, Control of infectious bovine rhinotracheitis in calves with a BHV-1 subunit iscom vaccine, Vaccine, 5: 525.CrossRefGoogle Scholar
  44. Trudel, M., Nadon, F., Seguin, C. and Brault, S., Lusignan, Y., and Lemieux, S., 1992, Initiation of cytotoxic T cell response and protection of BALB/c mice by vaccination with an experimental iscoms respiratory syncytial virus subunit vaccine. Vaccine, 10: 107.PubMedCrossRefGoogle Scholar
  45. Tsuda, T., Sugimura, T. and Murakami, Y., 1991, Evaluation of glycoprotein gII iscom subunit vaccine for pseudorabies in pig. Vaccine, 9: 648.PubMedCrossRefGoogle Scholar
  46. Van Binnendijk, R.S., Van Baalen, C.A., Poelen, M.C.M., De Vries, P., Boes, J., Cerundolo, V., Osterhaus, A.D.M.E. and UytdeHaag, F.G.C.M., 1992, Measles virus trans-membrane fusion protein synthesized de novo or presented in iscom is endogenously processed for HLA class I and class II restricted cytotoxic T cell recognition. J. Exp. Med., 176: 119.PubMedCrossRefGoogle Scholar
  47. Villacres-Eriksson, M., Bergström-Mollaoglu, M., Kåberg, H. and Morein, B. 1992, Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus iscoms. Scand. J. Immunol., 36: 421.PubMedCrossRefGoogle Scholar
  48. Villacres-Eriksson, M., Bergström-Mollaoglu, M., Kåberg, H., Lövgren, K. and Morein, B. 1993, The induction of cell-associated and secreted IL-1 by iscoms, matrix and micelles in murine splenic cells. Clin. Exp. Immunol., 93: 120.PubMedCrossRefGoogle Scholar
  49. Villacres-Eriksson, M. 1995, Antigen presentation by naive macrophages, dendritic cells and B cells to primed T lymphocytes and their cytokine production following exposure to immunostimulating complexes. Clin. Exp. Immunol., 102: 46.PubMedCrossRefGoogle Scholar
  50. Villacres-Eriksson, M., Behboudi, S., Morgan, A. J., Trinchieri, G., Morein, B. 1997, Immunomodulation by Ouillaja saponaria adjuvant formulations: in vivo stimulation of interteukin-12 and its effects on the antibody response. Cytokine, 9: 73.PubMedCrossRefGoogle Scholar
  51. Villacres-Eriksson, M., Nikkilä, T., Lövgren-Bengtsson, K. and Morein, B. Internalization of iscom-borne antigens and intracellular distribution in antigen-presenting cells. Submitted Manuscript.Google Scholar
  52. Visser, I.K.G., Van de Bildt, M.W.G., Brugge, H.N., Reijnders, P.J.M., Vedder, E.J., Kuiper, J., De Vries, P., Groen, J., Walvoort, H.C., UytdeHaag, F.G.C.M., and Osterhaus, A.D.M.E., 1989, Vaccination of harbour seals (Phoca vitulina) against phocid distemper with two different inactivated canine distemper virus (CDV) vaccines, Vaccine, 7: 521.PubMedCrossRefGoogle Scholar
  53. Watson, D.L., Watson, N.A., Fossum, C., Lövgren, K. and Morein, B. 1992, Interactions between immune-stimulating complexes (iscoms) and peritoneal mononuclear leucocytes. Microbiol. Immunol., 36: 119.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Maria Villacres-Eriksson
    • 1
  • Shahriar Behboudi
    • 1
  • Karin Lövgren-Bengtsson
    • 1
  • Bror Morein
    • 1
  1. 1.Section of Virology, Biomedical CentreSwedish University of Agricultural SciencesUppsalaSweden

Personalised recommendations